COSMO Pharmaceuticals N.V. header image

COSMO Pharmaceuticals N.V.

COPN

Equity

ISIN NL0011832936 / Valor 32590356

SIX Swiss Exchange (2026-01-30)
CHF 115.80+1.05%

COSMO Pharmaceuticals N.V.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

COSMO Pharmaceuticals N.V. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of gastrointestinal diseases. The company has successfully brought to market six approved drugs and two medical devices, addressing unmet medical needs in this therapeutic area. COSMO Pharmaceuticals is involved in the entire product lifecycle, from identifying medical needs and managing product development to obtaining regulatory approvals. The company licenses its approved products to partners with strong marketing and sales capabilities, ensuring effective market penetration. Additionally, COSMO offers a range of services related to pharmaceutical production, including the assessment of manufacturing processes, technology transfer, evaluation of product stability, market testing and release, and the preparation of necessary documentation for product registration.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

76.0%1Y
76.3%3Y
42.3%5Y

Performance

46.0%1Y
34.0%3Y
33.6%5Y

Volatility

Market cap

2389 M

Market cap (USD)

Daily traded volume (Shares)

26,758

Daily traded volume (Shares)

1 day high/low

63.8 / 61.5

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

CorVel Corp
CorVel Corp CorVel Corp Valor: 921843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.16%USD 69.63
Zoetis Inc
Zoetis Inc Zoetis Inc Valor: 19276994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.55%USD 124.82
HCA Healthcare Inc
HCA Healthcare Inc HCA Healthcare Inc Valor: 11321027
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.19%USD 488.27
Boston Scientific Corp
Boston Scientific Corp Boston Scientific Corp Valor: 913577
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.30%USD 93.53
Estee Lauder Companies Inc
Estee Lauder Companies Inc Estee Lauder Companies Inc Valor: 99350
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.06%USD 115.28
Humana Inc
Humana Inc Humana Inc Valor: 940174
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.75%USD 195.20
McKesson Corp
McKesson Corp McKesson Corp Valor: 991041
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.08%USD 831.21
TAL Education Group
TAL Education Group TAL Education Group Valor: 11869921
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 12.70
Neumora Therapeutics Inc
Neumora Therapeutics Inc Neumora Therapeutics Inc Valor: 129329732
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.93%USD 1.99
Robertet SA
Robertet SA Robertet SA Valor: 510354
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.63%EUR 846.00